Liver Regeneration-Related Genes of Nontumor Liver Tissues Predict the Prognosis of Patients with Hepatocellular Carcinoma

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156(2):477–491 e1. doi:10.1053/j.gastro.2018.08.065
   PubMed Web of Science ®Google Scholar
• Doycheva I, Thuluvath PJ. Systemic therapy for advanced hepatocellular carcinoma: an update of a rapidly evolving field. J Clin Exp Hepatol. 2019;9(5):588–596. doi:10.1016/j.jceh.2019.07.012
   PubMed Web of Science ®Google Scholar
• Goh EL, Chidambaram S, Ma S. Laparoscopic vs open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a meta-analysis of the long-term survival outcomes. Int J Surg. 2018;50:35–42. doi:10.1016/j.ijsu.2017.12.021
   PubMed Web of Science ®Google Scholar
• Xu LX, He MH, Dai ZH, et al. Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma. Ann Oncol. 2019;30(6):990–997. doi:10.1093/annonc/mdz103
   PubMed Web of Science ®Google Scholar
• Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology. 2006;43(2 Suppl 1):S45–53. doi:10.1002/hep.20969
   PubMed Web of Science ®Google Scholar
• Michalopoulos GK, Bhushan B. Liver regeneration: biological and pathological mechanisms and implications. Nat Rev Gastroenterol Hepatol. 2021;18(1):40–55. doi:10.1038/s41575-020-0342-4
   PubMed Web of Science ®Google Scholar
• Kwon YJ, Lee KG, Choi D. Clinical implications of advances in liver regeneration. Clin Mol Hepatol. 2015;21(1):7–13. doi:10.3350/cmh.2015.21.1.7
   PubMedGoogle Scholar
• Yagi S, Hirata M, Miyachi Y, Uemoto S. Liver regeneration after hepatectomy and partial liver transplantation. Int J Mol Sci. 2020;21(21):8414. doi:10.3390/ijms21218414
   PubMed Web of Science ®Google Scholar
• Chen D, Aierken A, Li H, Chen R, Ren L, Wang K. Identification of subclusters and prognostic genes based on glycolysis/gluconeogenesis in hepatocellular carcinoma. Front Immunol. 2023;14. doi:10.3389/fimmu.2023.1232390
   Web of Science ®Google Scholar
• Peng X, Shi Y, Zhang B, Xu C, Lang J. Establishment of nucleic acid sensing pathways-based model in predicting response to immunotherapy and targeted drug in hepatitis virus-related hepatocellular carcinoma. J Med Virol. 2023;95(9): e29084.
   PubMed Web of Science ®Google Scholar
• Afra F, Mahboobipour AA, Salehi Farid A, Ala M. Recent progress in the immunotherapy of hepatocellular carcinoma: non-coding RNA-based immunotherapy may improve the outcome. Biomed Pharmacother. 2023;165:115104. doi:10.1016/j.biopha.2023.115104
   PubMed Web of Science ®Google Scholar
• Li B, Xu T, Liu C, et al. Liver-enriched genes are associated with the prognosis of patients with hepatocellular carcinoma. Sci Rep. 2018;8(1):11197. doi:10.1038/s41598-018-29237-5
   PubMedGoogle Scholar
• Gong J, Li R, Chen Y, et al. HCC subtypes based on the activity changes of immunologic and hallmark gene sets in tumor and nontumor tissues. Briefings Bioinf. 2021;22(5). doi:10.1093/bib/bbaa427
   Web of Science ®Google Scholar
• Lin P, Wen DY, Pang JS, et al. Proteomics profiling of nontumor liver tissues identifies prognostic biomarkers in hepatitis B-related hepatocellular carcinoma. J Med Virol. 2023;95(1):e27732. doi:10.1002/jmv.27732
   PubMed Web of Science ®Google Scholar
• Aran D, Camarda R, Odegaard J, et al. Comprehensive analysis of normal adjacent to tumor transcriptomes. Nat Commun. 2017;8(1):1077. doi:10.1038/s41467-017-01027-z
   PubMedGoogle Scholar
• Jakubek YA, Chang K, Sivakumar S, et al. Large-scale analysis of acquired chromosomal alterations in non-tumor samples from patients with cancer. Nat Biotechnol. 2020;38(1):90–96. doi:10.1038/s41587-019-0297-6
   PubMed Web of Science ®Google Scholar
• Hoshida Y, Villanueva A, Kobayashi M, et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med. 2008;359(19):1995–2004. doi:10.1056/NEJMoa0804525
   PubMed Web of Science ®Google Scholar
• McCarthy DJ, Chen Y, Smyth GK. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012;40(10):4288–4297. doi:10.1093/nar/gks042
   PubMed Web of Science ®Google Scholar
• Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1–22. doi:10.18637/jss.v033.i01
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Mitchell C, Willenbring H. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc. 2008;3(7):1167–1170. doi:10.1038/nprot.2008.80
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen L, Wu X, et al. Acute liver steatosis translationally controls the epigenetic regulator MIER1 to promote liver regeneration in a study with male mice. Nat Commun. 2023;14(1):1521. doi:10.1038/s41467-023-37247-9
   PubMed Web of Science ®Google Scholar
• Caldez MJ, Bjorklund M, Kaldis P. Cell cycle regulation in NAFLD: when imbalanced metabolism limits cell division. Hepatol Int. 2020;14(4):463–474. doi:10.1007/s12072-020-10066-6
   PubMed Web of Science ®Google Scholar
• Li G, Guo GL. Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration. Acta Pharm Sin B. 2015;5(2):93–98. doi:10.1016/j.apsb.2015.01.005
   PubMed Web of Science ®Google Scholar
• Jia Y, Viswakarma N, Reddy JK. Med1 subunit of the mediator complex in nuclear receptor-regulated energy metabolism, liver regeneration, and hepatocarcinogenesis. Gene Expr. 2014;16(2):63–75. doi:10.3727/105221614X13919976902219
   PubMed Web of Science ®Google Scholar
• Braeuning A. Regulation of cytochrome P450 expression by Ras- and beta-catenin-dependent signaling. Curr Drug Metab. 2009;10(2):138–158. doi:10.2174/138920009787522160
   PubMed Web of Science ®Google Scholar
• Yang H, Guo J, Jin W, Chang C, Guo X, Xu C. A combined proteomic and metabolomic analyses of the priming phase during rat liver regeneration. Arch Biochem Biophys. 2020;693:108567. doi:10.1016/j.abb.2020.108567
   PubMed Web of Science ®Google Scholar
• Abu Rmilah A, Zhou W, Nelson E, Lin L, Amiot B, Nyberg SL. Understanding the marvels behind liver regeneration. Wiley Interdiscip Rev Dev Biol. 2019;8(3):e340. doi:10.1002/wdev.340
   PubMed Web of Science ®Google Scholar
• Li H, Li J, Qu X, et al. Establishment and validation of a novel lysosome-related gene signature for predicting prognosis and immune landscape in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2023;149(19):17543–17557. doi:10.1007/s00432-023-05477-5
   PubMed Web of Science ®Google Scholar
• Wu R, Gao Y, Zhao X, et al. Tumor biology, immune infiltration and liver function define seven hepatocellular carcinoma subtypes linked to distinct drivers, survival and drug response. Comput Biol Med. 2023:167. doi:10.1016/j.compbiomed.2023.107593
   Web of Science ®Google Scholar
• Zhu H, Lin Y, Lu D, et al. Proteomics of adjacent-to-tumor samples uncovers clinically relevant biological events in hepatocellular carcinoma. Natl Sci Rev. 2023. doi:10.1093/nsr/nwad167
   Web of Science ®Google Scholar
• Budhu A, Forgues M, Ye QH, et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell. 2006;10(2):99–111. doi:10.1016/j.ccr.2006.06.016
   PubMed Web of Science ®Google Scholar
• Wu J, Liu H, Wang H, et al. iTRAQ-based quantitative proteomic analysis of the liver regeneration termination phase after partial hepatectomy in mice. J Proteomics. 2022;267:104688. doi:10.1016/j.jprot.2022.104688
   PubMed Web of Science ®Google Scholar
• Xu WY, Shen Y, Zhu H, et al. 2-Aminoadipic acid protects against obesity and diabetes. J Endocrinol. 2019;243(2):111–123. doi:10.1530/joe-19-0157
   PubMed Web of Science ®Google Scholar
• Bezerra GA, Foster WR, Bailey HJ, et al. Crystal structure and interaction studies of human DHTKD1 provide insight into a mitochondrial megacomplex in lysine catabolism. IUCrJ. 2020;7(Pt 4):693–706. doi:10.1107/S205225252000696X
   PubMedGoogle Scholar
• Morvay PL, Baes M, Van Veldhoven PP. Differential activities of peroxisomes along the mouse intestinal epithelium. Cell Biochem Funct. 2017;35(3):144–155. doi:10.1002/cbf.3255
   PubMed Web of Science ®Google Scholar
• Mizuno Y, Ninomiya Y, Nakachi Y, et al. Tysnd1 deficiency in mice interferes with the peroxisomal localization of PTS2 enzymes, causing lipid metabolic abnormalities and male infertility. PLoS Genet. 2013;9(2):e1003286. doi:10.1371/journal.pgen.1003286
   PubMed Web of Science ®Google Scholar
• Ferdinandusse S, Zomer AW, Komen JC, et al. Ataxia with loss of Purkinje cells in a mouse model for refsum disease. Proc Natl Acad Sci U S A. 2008;105(46):17712–17717. doi:10.1073/pnas.0806066105
   PubMed Web of Science ®Google Scholar
• Qian L, Zhou C, Wang K, Li L, Xia W, Fan Y. An investigation of the prognostic role of genes related to lipid metabolism in head and neck squamous cell carcinoma. Int J Genomics. 2023;2023:9708282. doi:10.1155/2023/9708282
   PubMed Web of Science ®Google Scholar
• Zhengqi Q, Zezhi G, Lei J, He Q, Jinyao P, Ying A. Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC). Eur J Med Res. 2021;26(1):9. doi:10.1186/s40001-021-00482-1
   PubMed Web of Science ®Google Scholar
• Xiong Y, Si Y, Feng Y, Zhuo S, Cui B, Zhang Z. Prognostic value of lipid metabolism-related genes in head and neck squamous cell carcinoma. Immun Inflamm Dis. 2021;9(1):196–209. doi:10.1002/iid3.379
   PubMed Web of Science ®Google Scholar
• Xu R, Jiang W, Liu Y, et al. Single cell sequencing coupled with bioinformatics reveals PHYH as a potential biomarker in kidney ischemia reperfusion injury. Biochem Biophys Res Commun. 2022;602:156–162. doi:10.1016/j.bbrc.2022.02.095
   PubMed Web of Science ®Google Scholar